Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v3-EN Version v2-FR
Language English French
Date Updated 2020-03-11 2020-03-10
Drug Identification Number 02236783 02236783
Brand name ORCIPRENALINE ORCIPRENALINE
Common or Proper name ORCIPRENALINE ORCIPRENALINE
Company Name AA PHARMA INC AA PHARMA INC
Ingredients ORCIPRENALINE SULFATE ORCIPRENALINE SULFATE
Strength(s) 2MG 2MG
Dosage form(s) SYRUP SYRUP
Route of administration ORAL ORAL
Packaging size 250ML 250ML
ATC code R03CB R03CB
ATC description ADRENERGICS FOR SYSTEMIC USE ADRENERGICS FOR SYSTEMIC USE
Reason for discontinuation Business reasons Business reasons
Anticipated discontinuation date
Actual discontinuation date 2020-03-10 2020-03-10
Remaining supply date 2020-03-10 2020-03-10
Discontinuation status Discontinued To be discontinued
Discontinuation decision reversal no no
Information on remaining supply
Company comments
Health Canada comments